Identification of highly effective inhibitors against SARS-CoV-2 main protease: From virtual screening to in vitro study
Background and Objective: The public’s safety has been significantly jeopardized by the pandemic of COVID-19, which is brought on by the highly virulent and contagious SARS-CoV-2 virus. Finding novel antiviral drugs is currently of utmost importance for the treatment of patients with COVID-19. Main...
Main Authors: | Hu Wang, Jun Wen, Yang Yang, Hailin Liu, Song Wang, Xiaoli Ding, Chunqiao Zhou, Xuelin Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.1036208/full |
Similar Items
-
Noncovalent SARS-COV-2 main protease inhibitors: A virtual screening and molecular dynamic simulation study
by: Aoxiang Yan, et al.
Published: (2024-01-01) -
Finding potential inhibitors for Main protease (Mpro) of SARS-CoV-2 through virtual screening and MD simulation studies
by: N. Anis Ahamed, et al.
Published: (2023-12-01) -
Identification of a Putative SARS-CoV-2 Main Protease Inhibitor through In Silico Screening of Self-Designed Molecular Library
by: Nanxin Liu, et al.
Published: (2023-07-01) -
Screening of potential inhibitors targeting the main protease structure of SARS-CoV-2 via molecular docking
by: Xinbo Yang, et al.
Published: (2022-10-01) -
Towards potential inhibitors of COVID-19 main protease Mpro by virtual screening and molecular docking study
by: Moujane Soumia, et al.
Published: (2020-01-01)